The startup develops medical devices and functional ingredients specifically for oral cavity care, osteoarthritis, and aesthetic dermatology, utilizing targeted formulations for self-prescription. By out-licensing these products to a global network of partners, the company enhances treatment outcomes for patients with specific healthcare needs.
Funding
$2.4M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Patients with conditions like oral mucositis, osteoarthritis, and dermatological lesions often experience pain, discomfort, and impaired quality of life. Current treatments may have limitations in efficacy, tolerability, or ease of use, creating a need for more targeted and effective solutions.
Solution
BMG Pharma develops and out-licenses medical devices and functional ingredients designed to address specific needs in oral care, dermatology, and other therapeutic areas. The company leverages its expertise in biomaterials and drug delivery to create formulations that enhance treatment outcomes and improve patient compliance. BMG Pharma's products aim to provide targeted relief, promote healing, and restore function in a variety of clinical settings. By partnering with a global network of distributors, BMG Pharma ensures its innovative solutions reach patients worldwide.
Target Audience
The primary customers are healthcare providers, distributors, and ultimately patients seeking advanced solutions for oral care, dermatological conditions, and joint health.
Features
- Products utilizing the proprietary Hyaluromimethic® Technology
- Targeted formulations for oral mucositis, osteoarthritis, and aesthetic dermatology
- Focus on developing New Chemical Entities (NCEs) through chemical structure modification of biotechnological origin
- Development of innovative products based on scientific research
- Products designed to be interactive and effective for patients